Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of

Proposed roles of local and circulating plasminogen activator inhibitor

Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism - Frischmuth - 2022 - Journal of Thrombosis and Haemostasis - Wiley Online Library

PAI-1 is a vascular cell–specific HIF-2–dependent angiogenic factor that promotes retinal neovascularization in diabetic patients

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease - ScienceDirect

Therapeutics targeting the fibrinolytic system

Schematic diagram of the molecular mechanisms of the plasminogen

A novel ELISA for the detection of active form of plasminogen activator inhibitor-1 based on a highly specific trapping agent - ScienceDirect

Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease

A model for TGF-β1 induced PAI-1 transcription. Emerging studies

Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase

Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice

IJMS, Free Full-Text

Development of a plasminogen activator inhibitor (PAI-1) assay and comparison of plasma PAI-1 activity in hyperlipidemic/dyslipidemic dogs with either hyperadrenocorticism or diabetes mellitus, and healthy dogs - ScienceDirect

Figure 4 from Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.